BNP Paribas Financial Markets’s Axsome Therapeutics AXSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$19.5M Buy
186,437
+3,805
+2% +$397K 0.01% 800
2025
Q1
$21.3M Sell
182,632
-3,029
-2% -$353K 0.01% 737
2024
Q4
$15.7M Buy
185,661
+171,928
+1,252% +$14.5M 0.01% 796
2024
Q3
$1.23M Buy
13,733
+5,737
+72% +$516K ﹤0.01% 1703
2024
Q2
$644K Sell
7,996
-74,548
-90% -$6M ﹤0.01% 1892
2024
Q1
$6.59M Buy
82,544
+63,067
+324% +$5.03M 0.01% 906
2023
Q4
$1.55M Sell
19,477
-7,269
-27% -$579K ﹤0.01% 1534
2023
Q3
$1.87M Buy
26,746
+13,081
+96% +$914K ﹤0.01% 1393
2023
Q2
$982K Sell
13,665
-1,997
-13% -$144K ﹤0.01% 1655
2023
Q1
$966K Buy
15,662
+6,119
+64% +$377K ﹤0.01% 1785
2022
Q4
$736K Sell
9,543
-6,193
-39% -$478K ﹤0.01% 1740
2022
Q3
$702K Buy
15,736
+5,575
+55% +$249K ﹤0.01% 2103
2022
Q2
$389K Sell
10,161
-19,595
-66% -$750K ﹤0.01% 2175
2022
Q1
$1.23M Sell
29,756
-42,496
-59% -$1.76M ﹤0.01% 1686
2021
Q4
$2.73M Buy
72,252
+65,643
+993% +$2.48M ﹤0.01% 1308
2021
Q3
$218K Buy
6,609
+3,085
+88% +$102K ﹤0.01% 2428
2021
Q2
$238K Sell
3,524
-2,762
-44% -$186K ﹤0.01% 2245
2021
Q1
$356K Buy
6,286
+1,038
+20% +$58.8K ﹤0.01% 2222
2020
Q4
$428K Sell
5,248
-1,307
-20% -$106K ﹤0.01% 1922
2020
Q3
$467K Buy
6,555
+5,205
+386% +$371K ﹤0.01% 1679
2020
Q2
$111K Sell
1,350
-49,334
-97% -$4.06M ﹤0.01% 2114
2020
Q1
$2.98M Buy
50,684
+47,321
+1,407% +$2.78M 0.01% 907
2019
Q4
$348K Sell
3,363
-1,002
-23% -$104K ﹤0.01% 2058
2019
Q3
$88.3K Buy
4,365
+4,204
+2,611% +$85.1K ﹤0.01% 2564
2019
Q2
$4.15K Buy
161
+158
+5,267% +$4.07K ﹤0.01% 3636
2019
Q1
$43 Hold
3
﹤0.01% 3643
2018
Q4
$8 Hold
3
﹤0.01% 3616
2018
Q3
$10 Hold
3
﹤0.01% 3744
2018
Q2
$10 Hold
3
﹤0.01% 3741
2018
Q1
$7 Hold
3
﹤0.01% 3609
2017
Q4
$17 Hold
3
﹤0.01% 3497
2017
Q3
$17 Hold
3
﹤0.01% 3525
2017
Q2
$17 Sell
3
-66
-96% -$374 ﹤0.01% 3565
2017
Q1
$269 Sell
69
-154
-69% -$600 ﹤0.01% 3337
2016
Q4
$1.51K Sell
223
-533
-71% -$3.6K ﹤0.01% 3320
2016
Q3
$5.96K Buy
756
+316
+72% +$2.49K ﹤0.01% 3348
2016
Q2
$3.32K Buy
+440
New +$3.32K ﹤0.01% 3395